Boccellato, E.; Comba, L.; Tavarozzi, R.; Castellino, C.; Foglietta, M.; Mattei, D.; Ladetto, M.; Massaia, M.; Castellino, A.
Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells. Cancers 2025, 17, 2239.
https://doi.org/10.3390/cancers17132239
AMA Style
Boccellato E, Comba L, Tavarozzi R, Castellino C, Foglietta M, Mattei D, Ladetto M, Massaia M, Castellino A.
Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells. Cancers. 2025; 17(13):2239.
https://doi.org/10.3390/cancers17132239
Chicago/Turabian Style
Boccellato, Elia, Lorenzo Comba, Rita Tavarozzi, Claudia Castellino, Myriam Foglietta, Daniele Mattei, Marco Ladetto, Massimo Massaia, and Alessia Castellino.
2025. "Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells" Cancers 17, no. 13: 2239.
https://doi.org/10.3390/cancers17132239
APA Style
Boccellato, E., Comba, L., Tavarozzi, R., Castellino, C., Foglietta, M., Mattei, D., Ladetto, M., Massaia, M., & Castellino, A.
(2025). Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells. Cancers, 17(13), 2239.
https://doi.org/10.3390/cancers17132239